open access

Vol 17, No 3 (2012)
Original research articles
Published online: 2012-05-01
Submitted: 2011-10-31
Get Citation

Utilization of cone-beam CT for offline evaluation of target volume coverage during prostate image-guided radiotherapy based on bony anatomy alignment

Petr Paluska, Josef Hanus, Jana Sefrova, Lucie Rouskova, Jakub Grepl, Jan Jansa, Linda Kasaova, Miroslav Hodek, Milan Zouhar, Milan Vosmik, Jiri Petera
DOI: 10.1016/j.rpor.2012.03.003
·
Rep Pract Oncol Radiother 2012;17(3):134-140.

open access

Vol 17, No 3 (2012)
Original research articles
Published online: 2012-05-01
Submitted: 2011-10-31

Abstract

Aim

To assess target volume coverage during prostate image-guided radiotherapy based on bony anatomy alignment and to assess possibility of safety margin reduction.

Background

Implementation of IGRT should influence safety margins. Utilization of cone-beam CT provides current 3D anatomic information directly in irradiation position. Such information enables reconstruction of the actual dose distribution.

Materials and methods

Seventeen prostate patients were treated with daily bony anatomy image-guidance. Cone-beam CT (CBCT) scans were acquired once a week immediately after bony anatomy alignment. After the prostate, seminal vesicles, rectum and bladder were contoured, the delivered dose distribution was reconstructed. Target dose coverage was evaluated by the proportion of the CTV encompassed by the 95% isodose. Original plans employed a 1[[ce:hsp sp="0.25"/]]cm safety margin. Alternative plans assuming a smaller 7[[ce:hsp sp="0.25"/]]mm margin between CTV and PTV were evaluated in the same way. Rectal and bladder volumes were compared with the initial ones. Rectal and bladder volumes irradiated with doses higher than 75[[ce:hsp sp="0.25"/]]Gy, 70[[ce:hsp sp="0.25"/]]Gy, 60[[ce:hsp sp="0.25"/]]Gy, 50[[ce:hsp sp="0.25"/]]Gy and 40[[ce:hsp sp="0.25"/]]Gy were analyzed.

Results

In 12% of reconstructed plans the prostate coverage was not sufficient. The prostate underdosage was observed in 5 patients. Coverage of seminal vesicles was not satisfactory in 3% of plans. Most of the target underdosage corresponded to excessive rectal or bladder filling. Evaluation of alternative plans assuming a smaller 7[[ce:hsp sp="0.25"/]]mm margin revealed 22% and 11% of plans where prostate and seminal vesicles coverage, respectively, was compromised. These were distributed over 8 and 7 patients, respectively.

Conclusion

Sufficient dose coverage of target volumes was not achieved for all patients. Reducing of safety margin is not acceptable. Initial rectal and bladder volumes cannot be considered representative for subsequent treatment.

Abstract

Aim

To assess target volume coverage during prostate image-guided radiotherapy based on bony anatomy alignment and to assess possibility of safety margin reduction.

Background

Implementation of IGRT should influence safety margins. Utilization of cone-beam CT provides current 3D anatomic information directly in irradiation position. Such information enables reconstruction of the actual dose distribution.

Materials and methods

Seventeen prostate patients were treated with daily bony anatomy image-guidance. Cone-beam CT (CBCT) scans were acquired once a week immediately after bony anatomy alignment. After the prostate, seminal vesicles, rectum and bladder were contoured, the delivered dose distribution was reconstructed. Target dose coverage was evaluated by the proportion of the CTV encompassed by the 95% isodose. Original plans employed a 1[[ce:hsp sp="0.25"/]]cm safety margin. Alternative plans assuming a smaller 7[[ce:hsp sp="0.25"/]]mm margin between CTV and PTV were evaluated in the same way. Rectal and bladder volumes were compared with the initial ones. Rectal and bladder volumes irradiated with doses higher than 75[[ce:hsp sp="0.25"/]]Gy, 70[[ce:hsp sp="0.25"/]]Gy, 60[[ce:hsp sp="0.25"/]]Gy, 50[[ce:hsp sp="0.25"/]]Gy and 40[[ce:hsp sp="0.25"/]]Gy were analyzed.

Results

In 12% of reconstructed plans the prostate coverage was not sufficient. The prostate underdosage was observed in 5 patients. Coverage of seminal vesicles was not satisfactory in 3% of plans. Most of the target underdosage corresponded to excessive rectal or bladder filling. Evaluation of alternative plans assuming a smaller 7[[ce:hsp sp="0.25"/]]mm margin revealed 22% and 11% of plans where prostate and seminal vesicles coverage, respectively, was compromised. These were distributed over 8 and 7 patients, respectively.

Conclusion

Sufficient dose coverage of target volumes was not achieved for all patients. Reducing of safety margin is not acceptable. Initial rectal and bladder volumes cannot be considered representative for subsequent treatment.

Get Citation

Keywords

Prostate; Image-guided radiotherapy; Cone-beam computed tomography; Dose reconstruction; Dose-volume histogram

About this article
Title

Utilization of cone-beam CT for offline evaluation of target volume coverage during prostate image-guided radiotherapy based on bony anatomy alignment

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 17, No 3 (2012)

Pages

134-140

Published online

2012-05-01

DOI

10.1016/j.rpor.2012.03.003

Bibliographic record

Rep Pract Oncol Radiother 2012;17(3):134-140.

Keywords

Prostate
Image-guided radiotherapy
Cone-beam computed tomography
Dose reconstruction
Dose-volume histogram

Authors

Petr Paluska
Josef Hanus
Jana Sefrova
Lucie Rouskova
Jakub Grepl
Jan Jansa
Linda Kasaova
Miroslav Hodek
Milan Zouhar
Milan Vosmik
Jiri Petera

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl